We are live on ! Find out more
USNA icon

Usana Health Sciences

175 hedge funds and large institutions have $898M invested in Usana Health Sciences in 2019 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 37 increasing their positions, 74 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

60% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 20

13% more capital invested

Capital invested by funds: $798M → $898M (+$100M)

4% more funds holding

Funds holding: 169175 (+6)

0.45% more ownership

Funds ownership: 52.39%52.84% (+0.45%)

50% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 74

95% less call options, than puts

Call options by funds: $800K | Put options by funds: $17.7M

Holders
175
Holders Change
+6
Holders Change %
+3.55%
% of All Funds
3.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
32
Increased
37
Reduced
74
Closed
20
Calls
$800K
Puts
$17.7M
Net Calls
-$16.9M
Net Calls Change
-$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$158M +$2.32M +31,504 +2%
Renaissance Technologies
2
Renaissance Technologies
New York
$128M -$2.45M -33,200 -2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$105M -$27K -366 -0%
Acadian Asset Management
4
Acadian Asset Management
Massachusetts
$59.3M -$723K -9,815 -1%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$50.5M +$203K +2,759 +0.4%
State Street
6
State Street
Massachusetts
$31.2M +$1.07M +14,507 +4%
D.E. Shaw & Co
7
D.E. Shaw & Co
New York
$29.4M +$2.31M +31,296 +9%
Norges Bank
8
Norges Bank
Norway
$16.7M
Geode Capital Management
9
Geode Capital Management
Massachusetts
$16.4M +$76K +1,031 +0.5%
Northern Trust
10
Northern Trust
Illinois
$15.3M -$524K -7,119 -4%
Man Group
11
Man Group
United Kingdom
$13.8M +$1.44M +19,500 +12%
Morgan Stanley
12
Morgan Stanley
New York
$13.6M +$5.6M +76,053 +78%
N
13
Nuveen
North Carolina
$13.6M -$3.99M -54,209 -24%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$12.3M +$821K +11,142 +8%
Nordea Investment Management
15
Nordea Investment Management
Sweden
$12.2M -$22K -299 -0.2%
Russell Investments Group
16
Russell Investments Group
United Kingdom
$11.5M +$1.86M +25,272 +21%
MCM
17
Matarin Capital Management
New York
$10.5M -$4.22M -57,218 -30%
AQR Capital Management
18
AQR Capital Management
Connecticut
$10.2M -$3.96M -53,730 -29%
Charles Schwab
19
Charles Schwab
California
$9.65M +$448K +6,079 +5%
Ameriprise
20
Ameriprise
Minnesota
$8.49M -$262K -3,552 -3%
Principal Financial Group
21
Principal Financial Group
Iowa
$8.49M -$86.9K -1,179 -1%
JP Morgan Chase
22
JP Morgan Chase
New York
$7.59M +$2.48M +33,636 +53%
Hotchkis & Wiley Capital Management
23
Hotchkis & Wiley Capital Management
California
$7.38M +$627K +8,510 +10%
WA
24
Wasatch Advisors
Utah
$7.08M -$1.16M -15,751 -15%
Jacobs Levy Equity Management
25
Jacobs Levy Equity Management
New Jersey
$6.29M +$5.89M +80,009 New

USNA Hedge Fund Activity: Q4 2019 in Review

175 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2019, worth a combined $898M — up 13% from $798M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new USNA positions and 20 closed out — a net gain of 12 holders — while 37 added to existing stakes and 74 trimmed.

The largest buyer was Jacobs Levy Equity Management, opening a new position worth an estimated $5.89M. The largest seller was Schroder Investment Management Group, cutting an estimated $10M.

  • 175 institutional investors held Usana Health Sciences (USNA) as of Q4 2019, up from 169 in Q3 2019.
  • Funds reported $898M of Usana Health Sciences stock for Q4 2019, up 13% quarter-over-quarter.
  • 32 funds opened new Usana Health Sciences positions in Q4 2019 and 20 closed out, a net change of +12 holders.
  • The largest Usana Health Sciences buyer in Q4 2019 was Jacobs Levy Equity Management, an estimated $5.89M added.
  • The largest Usana Health Sciences seller in Q4 2019 was Schroder Investment Management Group, an estimated $10M sold.

Based on aggregated 13F filings for Q4 2019.